Ascendis Pharma A/S
ASND
252.73
-3.23
-1.26%
Ascendis Pharma A/S
US · ASND
#1127 by market cap
Listed 2015
252.73
-3.23
-1.26%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
- Founded
- 2006
- CEO
- Mr. Jan Moller Mikkelsen
- Employees
- 1,189
- Headquarters
- Hellerup, Capital Region, Denmark
- Fiscal year end
- 12-31
- Website
- ascendispharma.com
Company profile
- Exchange
- US
- Symbol
- ASND
- Market-cap rank
- #1127
- Listing date
- 2015-01-28
- Market cap
- 16.63B
- Float cap
- 16.62B
- Shares out
- 65.80M
- Float shares
- 65.77M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Ascendis Pharma A/S discussion 0 comments